SELLAS Life Sciences Grou... (SLS)

NASDAQ: SLS · Real-Time Price · USD

1.73

0.11 (6.79%)

At close: May 02, 2025, 3:59 PM

1.74

0.58%

After-hours: May 02, 2025, 05:35 PM EDT

SELLAS Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-30.88M	-37.34M	-41.3M	-20.7M	-16.76M	-19.29M	-27.67M	-23.75M	-11.1M
Depreciation & Amortization	n/a	n/a	457K	5.68M	282K	1.7M	3.76M	n/a	142K
Stock-Based Compensation	1.56M	1.39M	1.73M	1.01M	578K	573K	395K	3.17M	2.26M
Other Working Capital	-4.51M	1.04M	4.43M	-5.1M	6.43M	-1.12M	-2.07M	-2.3M	-24.16M
Other Non-Cash Items	561K	1.2M	10.13M	-4.16M	-87K	586K	4.42M	3.53M	-11.55M
Deferred Income Tax	n/a	n/a	-457K	-239K	-23K	-95K	-1.32M	n/a	243K
Change in Working Capital	-6.65M	3.35M	5.64M	-7.62M	5.59M	-1.11M	-10.01M	6.07M	-24.91M
Operating Cash Flow	-35.4M	-31.41M	-23.81M	-26.02M	-10.42M	-17.64M	-30.42M	-10.99M	-44.91M
Capital Expenditures	n/a	-5.5M	-4.5M	n/a	n/a	n/a	n/a	n/a	-6K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.81M	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-5.5M	-4.5M	n/a	n/a	n/a	n/a	n/a	-1.05M
Investing Cash Flow	n/a	-5.5M	-4.5M	n/a	n/a	n/a	n/a	1.81M	-1.06M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	-7.6M	-473K	16.5M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-487K	-675K	n/a
Other Financial Acitivies	594K	90K	85K	3.07M	8.84M	3.6M	n/a	n/a	n/a
Financial Cash Flow	46.76M	22.32M	24.08M	12.07M	38.44M	19.57M	23.12M	5.53M	34.32M
Net Cash Flow	11.36M	-14.6M	-4.23M	-13.95M	28.02M	1.93M	-7.3M	-3.64M	-11.65M
Free Cash Flow	-35.4M	-36.91M	-28.31M	-26.02M	-10.42M	-17.64M	-30.42M	-10.99M	-44.92M